# Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain

> **NCT00998062** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 30181 (estimated)

## Conditions studied

- Dyslipaemia
- Atherosclerosis Risk
- Increased hsCRP
- Inflammatory and Oxidative Status in the Spanish Population

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00998062
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 30181 (ESTIMATED)
- **Last updated:** 2011-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00998062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00998062, "Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00998062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*